Eldorado Gold (EGO) Q2 2026 Earnings Call Transcript

Eldorado Gold reported Q2 2026 revenue of $487M (vs. $452M a year ago) as realized gold price rose to $4,379/oz, supporting net earnings of $173M (EPS $0.68). Despite lower legacy production, adjusted net earnings improved to $137M ($0.54/share) and cash ended at $555M, but free cash flow was -$334M due to $214M of Skouries spend and $78M for McIlvenna Bay ramp-up. Management emphasized peak leverage at $1.75B total debt while targeting McIlvenna Bay commercial production in Q3; Skouries commissioning is progressing with grid connection expected end-August (risk of slip to September mitigated by 36MW on-site gensets).

Analysis

EGO is moving from a capex story to a cash-conversion story, and that transition is the real equity catalyst. Once the market believes both projects are genuinely inside the last mile, the stock should start trading less like a development optionality name and more like a levered producer with a de-risking balance sheet; that usually compresses the discount rate faster than near-term production adds NAV. The catch is that the rerating depends on execution cadence, not just milestone language, so even a 2-6 week slip mainly matters because it pushes more costs into capitalized buckets and delays the optics of deleveraging.

The second-order winners are the local service providers and midstream/processing ecosystem around each asset, but the more interesting competitive effect is on comparable gold developers: EGO’s ability to advance a copper-linked project while preserving liquidity raises the bar for peers that still need dilution or expensive project finance. For the broader complex, a successful ramp would also create a small but important self-funded growth engine that can support buybacks/dividends later, which is a better multiple driver than spot gold alone. The losers are higher-cost gold producers and developers whose equity stories remain hostage to funding markets; EGO’s balance-sheet inflection highlights their weaker financing optionality.

Near term, the market should focus on three catalysts: grid connection in Greece, commercial production declarations in the next 30-60 days, and evidence that McIlvenna Bay turns cash generative by year-end. The main falsifier is any indication that commissioning issues are fundamental rather than just timing/availability; if Q3 commentary suggests throughput stalls below the stated commercialization band or if the Greece energization moves materially beyond September, the stock likely reverts to “project risk” mode. Over 6-18 months, the thesis only works if leverage starts falling into 2027 and ramp-up costs normalize; otherwise the company remains trapped in a high-beta earnings bridge trade, not a durable rerating story.

Key Decisions for Investors

• Initiate a modest long EGO position on any post-call weakness, with a 1-3 month horizon into Skouries grid connection and McIlvenna Bay commercialization; thesis works if the market starts discounting peak leverage and year-end FCF inflection.
• Prefer a call spread over outright equity for event exposure: buy EGO 3-6 month calls and finance partly with a higher strike sale to express upside to Q3/Q4 de-risking while capping premium if commissioning slips.
• Pair trade: long EGO / short GDXJ for the next 1-3 months. EGO has a clearer idiosyncratic catalyst path; the short leg hedges gold beta while isolating execution-driven rerating potential.
• Set a hard risk alert on Skouries grid connection slipping materially beyond September or McIlvenna Bay failing to maintain 60%-80% throughput for 30+ days; that would invalidate the near-term rerating thesis and should reduce exposure.
• For longer-term accounts, hold off on aggressive sizing until Q4 commentary confirms positive FCF at McIlvenna Bay and a visible step-down in project capex/debt. If those show up, the stock can migrate from story equity to cash-flow equity, which is the better 6-18 month setup.